|1.||Centers for Disease Control and Prevention (CDC): 19 articles (08/2014 - 02/2000)|
|2.||Van Damme, Pierre: 8 articles (01/2013 - 07/2002)|
|3.||Smith, Philip J: 8 articles (04/2011 - 06/2004)|
|4.||Liang, Xiaofeng: 7 articles (11/2015 - 01/2013)|
|5.||Cui, Fuqiang: 6 articles (11/2015 - 12/2013)|
|6.||Zhang, Li: 6 articles (11/2015 - 04/2009)|
|7.||Chen, Robert T: 6 articles (09/2011 - 06/2002)|
|8.||Wang, Fuzhen: 5 articles (11/2015 - 04/2013)|
|9.||DeStefano, Frank: 5 articles (04/2005 - 06/2002)|
|10.||Launay, Odile: 4 articles (11/2015 - 04/2007)|
02/01/1983 - "The protective efficacy of a hepatitis B vaccine against infections from transfusions of large volumes of highly infective blood in five immunized chimpanzees was assessed. "
05/01/1993 - "Hepatitis B vaccine has demonstrated to be very effective and safe preventing hepatitis B virus infection. "
07/01/1992 - "Thus, immune responses and efficacy of hepatitis B vaccine in infants were excellent, and immunity and protection against clinically significant HBV infection persisted for at least 5 to 10 years, features essential to success of a program of universal childhood immunization against HBV."
10/09/1980 - "We assessed the efficacy of an inactivated hepatitis B vaccine in a placebo-controlled, randomized, double-blind trial in 1083 homosexual men known to be at high risk for hepatitis B virus infection. "
09/01/1999 - "Thus, immunization of chimpanzees with licensed recombinant hepatitis B vaccines stimulates anti-HBs that is broadly reactive and affords protection against infection with a surface gene mutant of HBV, suggesting that properly immunized individuals are not at significant risk of infection with this prototype variant strain of HBV."
08/01/2010 - "Vaccination is the measure that is most effective in reducing the global incidence of hepatitis B and hepatitis B vaccines have now been available for over 20 years. "
10/21/1976 - "They may be important determinants in assessing infectivity of chronic carriers of HBs Ag and in evaluating efficacy of hepatitis B immune globulin and hepatitis B vaccines."
12/01/2011 - "The current immunization schedule for hepatitis B vaccine includes a dose given as early as possible after birth, preferably within 24 hours for all institutional deliveries because the birth dose of Hepatitis B vaccine is effective in preventing perinatal transmission of Hepatitis B. "
01/01/1993 - "The hepatitis B vaccine, which was introduced to use in Thailand in 1985, seems to be effective in reducing the prevalence of hepatitis B carriers year after year. "
01/01/1985 - "Follow-up studies have demonstrated the effect of this prevention, and the newly developed hepatitis B vaccine has further improved the possibilities for effective prophylaxis against occupational hepatitis B. "
|3.||Chronic Hepatitis B
03/01/2002 - "It may be concluded that recombinant hepatitis B vaccine is effective in the treatment of chronic hepatitis B."
04/01/2007 - "Efficacy of hepatitis B vaccine in susceptible spouses of chronic hepatitis B virus infected individuals at the time of marriage."
12/01/2007 - "To study the specific cellular immunoresponse of peripheral blood lymphocytes in the chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine. "
09/01/2014 - "Surface protein mutations in chronic hepatitis B patients who received hepatitis B vaccine therapy."
12/01/2007 - "The recombinant hepatitis B vaccine may increase the function of specific T lymphocytes in patients with chronic hepatitis B. "
12/01/1988 - "Hepatitis remains a problem, but this risk may be reduced to some degree through immunization with hepatitis B vaccines that have recently been proved safe and effective."
01/01/1997 - "Prophylaxis of acute viral hepatitis by immune serum globulin, hepatitis B vaccine, and health education: a sixteen year study of Japan overseas cooperation volunteers."
02/01/1978 - "The serologic diagnosis of non-A non-B hepatitis is a diagnosis of exclusion for assay systems for this form of disease are not yet available.A prototype hepatitis B vaccine has been prepared and is currently undergoing clinical trials. "
08/01/2012 - "Thirty patients received hepatitis B vaccine and 80% responded (hepatitis Bs titres ≥10 mIU/ml). "
03/28/2003 - "The status and likely impact of existing and potential new combined hepatitis B vaccines were broadly considered at the Viral Hepatitis Prevention Board (VHPB) meeting in Malta, October 2001. "
04/01/2007 - "They represent a major overhang in the vaccinology field, and, as anti-hepatitis B vaccine, will probably be effective in cancer prevention. "
09/01/2011 - "Randomized trial of the immunogenicity and safety of the Hepatitis B vaccine given in an accelerated schedule coadministered with the human papillomavirus type 16/18 AS04-adjuvanted cervical cancer vaccine."
06/01/2002 - "The administration of pre-S2-containing hepatitis B vaccines may give a better seroconversion and higher antibody response to vaccination in children with cancer. "
11/01/1995 - "Serologic responses to hepatitis B vaccine were investigated in 197 pediatric cancer patients. "
06/01/2011 - "Children born in counties with higher hepatitis B vaccine coverage had lower odds of all cancers combined (OR = 0.81, 95% CI: 0.67 to 0.98) and acute lymphoblastic leukemia (ALL) specifically (OR = 0.63, 95% CI: 0.46 to 0.88). "
|1.||Hepatitis B Surface Antigens (HBsAg)
|3.||hepatitis B hyperimmune globulin
|5.||Hepatitis B e Antigens
|6.||Recombinant DNA (Recombinant DNA Research)
|8.||DNA (Deoxyribonucleic Acid)
|9.||Hepatitis B Vaccines (Hepatitis B Vaccine)
|1.||Renal Dialysis (Hemodialysis)
|2.||Transplantation (Transplant Recipients)
|4.||Drug Therapy (Chemotherapy)